Drugs / InbioDerm+C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05234086 | Jan 2020 → May 2022 | — | Instituto para el Desarrollo Biotecnológico y la Innovación S.A. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | InbioDerm+C | “The product to be evaluated corresponds to a combined medical device, which conveys a cellular therapy, known as InbioDerm+C.” NCT05234086 ↗ |
| Modality | Cell therapy | “conveys a cellular therapy” NCT05234086 ↗ |